(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate

Compound number
MolPort-044-754-028
CAS number
138-12-5; 51-34-3
IUPAC
(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
IUPAC traditional
(2R,4S)-9-methyl-3-oxa-9-azatricyclo[3.3.1.0²,⁴]nonan-7-yl (2S)-3-hydroxy-2-phenylpropanoate
SMILES
CN1C2CC(CC1[C@@H]1O[C@H]21)OC(=O)[C@H](CO)c1ccccc1 |r,THB:10:4:1:9.7,8:9:1:5.4.3,8:7:1:5.4.3|
InChI key
STECJAGHUSJQJN-XSZHVHBUSA-N
Molecular formula
Molecular weight
303.358
Solubility
not available

Warning!
This substance is controlled or otherwise illegal in the following legislations. Please make certain that it is acceptable for import into your Order's intended destination country.

Compliance Information

China CN Toxic Drugs for Medicinal Use

Marketplace Offers

ChemFaces

Direct S&H to USA 50.00 USD Direct S&H to World: 50.00 USD
Catalog
Screening compound
Ships out
7 business days
Purity
>=98%
Last updated
> 3 months ago
In warehouse
Unverified

Supplier Catalogue Data

Pack size Ships out Price Quantity
5 mg June 2, 2022 418.00 USD
Add to Cart Buy

More Information

Compound identifiers

Compound number
MolPort-044-754-028
CAS number
138-12-5; 51-34-3

Names, Synonyms and 3rd Party Identifiers

Name
Atroscine
Scopolamine

InChI

InChI
1/C17H21NO4/c1-18-13-7-11(8-14(18)16-15(13)22-16)21-17(20)12(9-19)10-5-3-2-4-6-10/h2-6,11-16,19H,7-9H2,1H3/t11?,12-,13?,14?,15-,16+/m1/s1
InChI key
STECJAGHUSJQJN-XSZHVHBUSA-N

Formula

Molecular formula
C17H21NO4
Molecular weight
303.358

MolPort Guarantee

When you purchase products through the MolPort website from any seller other than MolPort itself, you will be protected by the MolPort Guarantee. If you purchase products from MolPort itself, this MolPort Guarantee will not apply, and your remedies will be governed by the MolPort Terms of Sale and Supply.

Copyright 2022 MolPort. All rights reserved. v5.96

We use cookies to improve your experience on our websites and for advertising. Learn more Accept

Feedback